 |
 |
The treatment of patients with HIV infection is a complex process that includes testing, diagnosis, linkage to care, individualized antiretroviral therapy (ART), and the management of co-morbidities (especially hepatitis C co-infection) and other issues. Decisions about the clinical managment of HIV patients often require that clinicians understand a wide range of clinical trial data and treatment information if they are to provide the care that is best suited for each patient. This is especially true of ART and includes critically important issues regarding when to start, which antiretrovirals (ARVs) to use and when to switch.
This two-part medical education program includes a combination of online teaching modules and Q&A sessions with nationally recognized HIV specialists. As a result of participating in this program, physicians and other health care providers will gain a greater understanding of how to provide optimal therapy for patients with HIV infection, thereby increasing the number of patients receiving individualized, optimal ARV therapy, while reducing morbidity and mortality and improving patient outcomes.
The first part of the program includes a choice of three online modules that address: 1) regimen selection for the treatment-naïve patient; 2) regimen selection for the treatment-experienced patient; and 3) prevention and management of common co-morbidities in the HIV- infected patient. Once a module is completed and CME credit has been awarded, the participant will then be offered an opportunity to participate in a Q&A session via text, email or teleconference, scheduled with one of a panel of HIV faculty for a more in-depth discussion of the module topics.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals actively involved in the treatment and management of patients with HIV-infection. It is tuition-free and there are no prerequisites.
Upon completion of the program, participants should be better able to:
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
Joseph Eron, MD
Professor
University of North Carolina
School of Medicine
Chapel Hill, North Carolina
Paul Sax, MD
Clinical Director
Division of Infectious Diseases
Brigham and Women's Hospital
Professor of Medicine
Harvard Medical School
Boston, Massachusetts
| Roberto Arduino, MD University of Texas, Houston |
David Bamberger, MD University of Missouri Kansas City |
| Rafael Campo, MD University of Miami |
Lisa Capaldini, MD University of California San Francisco |
| Richard Elion, MD Whitman-Walker Clinic, Washington DC |
Ian Frank, MD University of Pennsylvania |
| Trevor Hawkins, MD Southwest CARE, Santa Fe |
David Hardy, MD University of California Los Angeles |
| Charles Hicks, MD University of California San Diego |
Dushyantha Jayaweera, MD University of Miami |
| Daniel Lee, MD University of California San Diego |
Renslow Sherer, MD University of Chicago |
| Michael Sension, MD Comprehensive Care Center, Ft. Lauderdale |
1) Regimen Selection for the Treatment-Naïve Patient
2) Regimen Selection for the Treatment-Experienced Patient
3) Prevention and Management of Common Co-Morbidities in the HIV-Infected Patient
Media: Internet
Release Date: April 22, 2014
Expiration Date: April 22, 2015
Please click button below to launch module menu.
Click here to view Participation Instructions.
Upon the completion of each module, and passing the corresponding CME post-tests, each participant will have an opportunity to have a Q&A Session with one of the faculty members. This session can take place via email, text or teleconference. The primary purpose of this session will be to answer questions or provide information regarding the completed modules; however, other areas of interest may also be addressed at the discretion of the faculty member.
Note that once a Q&A session is requested, a confirmation will be sent within 48 hours of the request. Once the session request has been confirmed, any text/email requests will then be sent to a faculty member with a response from them given within one week of request. If a teleconference was requested, the scheduling process will begin for a 15-minute call which would be scheduled within one month of the initial request, based on faculty availability.
Click the button below to request a Q&A Session with a faculty member once you have completed a module and received CME credit.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Regimen Selection for the Treatment-Naïve Patient
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Regimen Selection for the Treatment-Experienced Patient
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.0 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Prevention and Management of Common Co-Morbidities in the HIV-Infected Patient
The Postgraduate Institute for Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:
Calvin Cohen, MD
Joseph Eron, MD
Paul Sax, MD
The following PIM planners and managers, Laura Excell, ND, NP, MS, MA, LPC, NCC, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CCMEP, and Jan Schultz, RN, MSN, CCMEP hereby state that they or their spouse/life partner do not have any financial relationships or relationships to products or devices with any commercial interest related to the content of this activity of any amount during the past 12 months.
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
There are no fees for participating and receiving CME credit for this activity. During the period, April 22, 2014 through April 22, 2015, participants must read the learning objectives and faculty disclosures and study the educational activity.
PIM supports Green CME by offering your Request for Credit online. If you wish to received acknowledgment of completing this activity, please complete the post-test and evaluation on www.cmeuniveristy.com. On the navigation menu, click on "Find Post-test/Evaluation by Course" and search by course ID (Sax/Experienced Module: 9908; Cohen/Naïve Module: 9909; Eron/Co-Morbidities Module: 9910). Upon registering and successfully completing the post-test with a score of 70% or better and the activity evaluation, your certificate will be made available immediately. Processing credit requests online will reduce the amount of paper used by nearly 100,000 sheets per year.
